Status Migrainosus
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Intravenous Erenumab in Patients With Status Migrainosus (NCT04920331) | Mayo Clinic | 2021-09-07 |
Track Status Migrainosus automatically
Every clearance here is in the API, with alerts when new ones post.